Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05740540 · ClinicalTrials.gov registry record · NA

Implant for Walking After Stroke

A NA study of Stroke and Hemiplegia, sponsored by MetroHealth Medical Center.

Recruiting
Registry status
NA
Development phase
6
Enrollment target
2
Study locations

NCT05740540 is a NA study of Stroke and Hemiplegia that is actively recruiting participants, run by MetroHealth Medical Center. The registered enrollment target is 6 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05740540, a NA study of Stroke and Hemiplegia, is actively recruiting participants, sponsored by MetroHealth Medical Center.

RECRUITING
Registry status
NA
Development phase
6 participants
Enrollment target
2
Study locations

Study Summary

This is a device study that will evaluate the effect of an implanted stimulator on improving walking in stroke survivors. There are two phases in the study: 1) Screening - this phase determines if the individual is a good candidate to receive an implanted system, 2) Implantation, controller development, and evaluation - this phase includes installing the device and setting the individual up for home use, creating advanced controllers for walking and evaluating the effect of the device over several months.

Interventions

  • DEVICE IRS-8
  • DEVICE IST 12 & IST 16

Study Locations (2)

Ohio

  • Louis Stokes Cleveland Veterans Affairs Medical Center - Cleveland
  • MetroHealth Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2023-05-16
Est. Completion 2027-06-30
Phase NA

Sponsor

MetroHealth Medical Center

76 total trials

What the Registry Record Tells You About NCT05740540

The ClinicalTrials.gov registry entry for NCT05740540 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which IRS-8 is the first listed.

NCT05740540 reports 2 study locations spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05740540 about?

NCT05740540 is a clinical study titled "Implant for Walking After Stroke". This is a device study that will evaluate the effect of an implanted stimulator on improving walking in stroke survivors. There are two phases in the study: 1) Screening - this phase determines if the individual is a good candidate to receive an implanted system, 2) Implantation, controller developm...

What is the current status of trial NCT05740540?

This trial is currently recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2023-05-16. Estimated completion is 2027-06-30.

What conditions does trial NCT05740540 study?

This clinical trial studies the following conditions: Stroke, Hemiplegia, Gait, Hemiplegic.

What interventions are being tested in trial NCT05740540?

The interventions under investigation include: IRS-8 (DEVICE), IST 12 & IST 16 (DEVICE).

Who is sponsoring clinical trial NCT05740540?

This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05740540 being conducted?

This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.